Compaq to Invest $10M for 2.2 Percent Stake in Geneva Proteomics | GenomeWeb

NEW YORK, Oct 2 - Compaq Computer (NYSE: CPQ) of Houston will make a $10 million direct investment in Geneva Proteomics in exchange for 2.2 percent of GeneProt’s equity, Cedric Loiret-Bernal, CEO of GeneProt, said Monday.

Loiret-Bernal also said the Geneva-based GeneProt would use Compaq Global Services, StorageWorks, and AlphaServer systems in its proteomic research facilities, which are scheduled to open in 2001.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.